NEW YORK, Nov. 14, 2012 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
TechNavio's analysts forecast the Global Diabetes Drugs market to grow at a CAGR of 9.7 percent over the period 2011-2015. One of the key factors contributing to this market growth is the increase in diabetic population. The Global Diabetes Drugs market has also been witnessing the trend of increasing awareness and education. However, the increasing use of complementary and alternative medicine (CAM) could pose a challenge to the growth of this market.
TechNavio's report, the Global Diabetes Drugs Market 2011-2015, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers Americas, and the EMEA and APAC regions; it also covers the Global Diabetes Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.
Key vendors dominating this space include Eli Lilly and Co., Merck and Co. Inc., Novo Nordisk A/S and Sanofi S.A.
Key questions answered in this report:
What will the market size be in 2015 and at what will be the growth rate?
What are key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by key vendors?
What are the strengths and
Copyright©2012 PR Newswire.
All rights reserved